Burns, S. P., Xing, D. & Shapley, R. M. Comparisons of the dynamics of local field potential and multiunit activity signals in macaque visual cortex. J. Neurosci. 30, 13739–13749 (2010).
Ahmadi, N., Constandinou, T. G. & Bouganis, C. S. Inferring entire spiking activity from local field potentials. Sci. Rep. 11, 19045 (2021).
Tseng, H. A. & Han, X. Distinct spiking patterns of excitatory and inhibitory neurons and LFP oscillations in prefrontal cortex during sensory discrimination. Front. Physiol. 12, 618307 (2021).
Cho, K. K. et al. Gamma rhythms link prefrontal interneuron dysfunction with cognitive inflexibility in Dlx5/6+/− mice. Neuron 85, 1332–1343 (2015).
Helfrich, R. F. & Knight, R. T. Oscillatory dynamics of prefrontal cognitive control. Trends Cogn. Sci. 20, 916–930 (2016).
Kamigaki, T. & Dan, Y. Delay activity of specific prefrontal interneuron subtypes modulates memory-guided behavior. Nat. Neurosci. 20, 854–863 (2017).
Pinto, L. & Dan, Y. Cell-type-specific activity in prefrontal cortex during goal-directed behavior. Neuron 87, 437–450 (2015).
Lagler, M. et al. Divisions of identified parvalbumin-expressing basket cells during working memory-guided decision making. Neuron 91, 1390–1401 (2016).
Kvitsiani, D. et al. Distinct behavioural and network correlates of two interneuron types in prefrontal cortex. Nature 498, 363–366 (2013).
Liebe, S., Hoerzer, G. M., Logothetis, N. K. & Rainer, G. Theta coupling between V4 and prefrontal cortex predicts visual short-term memory performance. Nat. Neurosci. 15, 456–462 (2012).
Buschman, T. J., Denovellis, E. L., Diogo, C., Bullock, D. & Miller, E. K. Synchronous oscillatory neural ensembles for rules in the prefrontal cortex. Neuron 76, 838–846 (2012).
Hsieh, H. L., Wong, Y. T., Pesaran, B. & Shanechi, M. M. Multiscale modeling and decoding algorithms for spike-field activity. J. Neural Eng. 16, 016018 (2019).
Fu, Z. et al. The geometry of domain-general performance monitoring in the human medial frontal cortex. Science 376, eabm9922 (2022). This study is an example of using Behnke–Fried electrodes to collect single neuron activity in large patient cohorts.
Steinmetz, N. A., Koch, C., Harris, K. D. & Carandini, M. Challenges and opportunities for large-scale electrophysiology with Neuropixels probes. Curr. Opin. Neurobiol. 50, 92–100 (2018).
Chung, J. E. et al. High-density single-unit human cortical recordings using the Neuropixels probe. Neuron 110, 2409–2421.e3 (2022).
Khanna, A. R. et al. Single-neuronal elements of speech production in humans. Nature 626, 603–610 (2024).
Leonard, M. K. et al. This study highlights use of Neuropixels for investigating columnar processing in human speech encoding. Nature 626, 593–602 (2024). This study highlights the use of Neuropixels probes for investigating columnar processing in human speech encoding.
Trautmann, E. M. et al. Large-scale high-density brain-wide neural recording in nonhuman primates. Preprint at bioRxiv https://doi.org/10.1101/2023.02.01.526664 (2023).
Tischbirek, C. H. et al. In vivo functional mapping of a cortical column at single-neuron resolution. Cell Rep. 27, 1319–1326.e5 (2019).
Khodagholy, D. et al. NeuroGrid: recording action potentials from the surface of the brain. Nat. Neurosci. 18, 310–315 (2015).
Tchoe, Y. et al. Human brain mapping with multithousand-channel PtNRGrids resolves spatiotemporal dynamics. Sci. Transl. Med. 14, eabj1441 (2022).
Paulk, A. C. et al. Microscale physiological events on the human cortical surface. Cereb. Cortex 31, 3678–3700 (2021).
Paulk, A. C. et al. Large-scale neural recordings with single neuron resolution using Neuropixels probes in human cortex. Nat. Neurosci. 25, 252–263 (2022). Refs. 15 and 23 were among the first studies to demonstrate the use of Neuropixels probes in human cortex.
Bugeon, S. et al. A transcriptomic axis predicts state modulation of cortical interneurons. Nature 607, 330–338 (2022).
Pollen, A. A. et al. Low-coverage single-cell mRNA sequencing reveals cellular heterogeneity and activated signaling pathways in developing cerebral cortex. Nat. Biotechnol. 32, 1053–1058 (2014).
Nowakowski, T. J. et al. Spatiotemporal gene expression trajectories reveal developmental hierarchies of the human cortex. Science 358, 1318–1323 (2017). This study applies next-generation single-cell RNA sequencing technologies to profile human cortical cell atlases in brain development.
Darmanis, S. et al. A survey of human brain transcriptome diversity at the single cell level. Proc. Natl Acad. Sci. USA 112, 7285–7290 (2015).
Macosko, E. Z. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202–1214 (2015). This study introduces a key method in development of next-generation single-cell RNA sequencing technologies.
Langlieb, J. et al. The molecular cytoarchitecture of the adult mouse brain. Nature 624, 333–342 (2023).
Yao, Z. et al. A high-resolution transcriptomic and spatial atlas of cell types in the whole mouse brain. Nature 624, 317–332 (2023). This study uses single-cell RNA sequencing and spatial transcriptomics to map the entire mouse brain.
Siletti, K. et al. Transcriptomic diversity of cell types across the adult human brain. Science 382, eadd7046 (2023). This study provides an initial draft of a cell atlas of the human brain.
Clark, I. C. et al. Microfluidics-free single-cell genomics with templated emulsification. Nat. Biotechnol. 41, 1557–1566 (2023).
Bakken, T. E. et al. Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nature 598, 111–119 (2021). This study is an example that highlights unique cell-type-specific transcriptomic and physiologic properties of human neurons compared to model systems.
Luo, C. et al. Single-cell methylomes identify neuronal subtypes and regulatory elements in mammalian cortex. Science 357, 600–604 (2017).
Ziffra, R. S. et al. Single-cell epigenomics reveals mechanisms of human cortical development. Nature 598, 205–213 (2021).
Luo, C. et al. Single nucleus multi-omics identifies human cortical cell regulatory genome diversity. Cell Genomics 2, 100107 (2022).
Gatto, L. et al. Initial recommendations for performing, benchmarking and reporting single-cell proteomics experiments. Nat. Methods 20, 375–386 (2023).
Alon, S. et al. Expansion sequencing: spatially precise in situ transcriptomics in intact biological systems. Science 371, eaax2656 (2021).
Niu, M. et al. Droplet-based transcriptome profiling of individual synapses. Nat. Biotechnol. 41, 1332–1344 (2023).
Zeng, H. What is a cell type and how to define it. Cell 185, 2739–2755 (2022).
Fang, R. et al. Conservation and divergence of cortical cell organization in human and mouse revealed by MERFISH. Science 377, 56–62 (2022).
Zhang, D. et al. Spatial epigenome-transcriptome co-profiling of mammalian tissues. Nature 616, 113–122 (2023).
Wang, X. et al. Three-dimensional intact-tissue sequencing of single-cell transcriptional states. Science 361, eaat5691 (2018).
Glasser, M. F. et al. A multi-modal parcellation of human cerebral cortex. Nature 536, 171–178 (2016).
Liharska, L. E. et al. A study of gene expression in the living human brain. Preprint at medRxiv https://doi.org/10.1101/2023.04.21.23288916 (2023).
Schneider, A. et al. Transcriptomic cell type structures in vivo neuronal activity across multiple timescales. Cell Rep. 42, 112318 (2023).
Ting, J. T. et al. A robust ex vivo experimental platform for molecular-genetic dissection of adult human neocortical cell types and circuits. Sci. Rep. 8, 8407 (2018).
Beaulieu-Laroche, L. et al. Enhanced dendritic compartmentalization in human cortical neurons. Cell 175, 643–651.e14 (2018).
Moradi Chameh, H. et al. Diversity amongst human cortical pyramidal neurons revealed via their sag currents and frequency preferences. Nat. Commun. 12, 2497 (2021).
Kalmbach, B. E. et al. h-Channels contribute to divergent intrinsic membrane properties of supragranular pyramidal neurons in human versus mouse cerebral cortex. Neuron 100, 1194–1208.e5 (2018).
Beaulieu-Laroche, L. et al. Allometric rules for mammalian cortical layer 5 neuron biophysics. Nature 600, 274–278 (2021).
Berto, S. et al. Gene-expression correlates of the oscillatory signatures supporting human episodic memory encoding. Nat. Neurosci. 24, 554–564 (2021).
Mahalingam, G. et al. A scalable and modular automated pipeline for stitching of large electron microscopy datasets. eLife 11, e76534 (2022).
Chen, X. et al. High-throughput mapping of long-range neuronal projection using in situ sequencing. Cell 179, 772–786.e19 (2019).
Foss-Feig, J. H. et al. Searching for cross-diagnostic convergence: neural mechanisms governing excitation and inhibition balance in schizophrenia and autism spectrum disorders. Biol. Psychiatry 81, 848–861 (2017).
Krystal, J. H. et al. Impaired tuning of neural ensembles and the pathophysiology of schizophrenia: a translational and computational neuroscience perspective. Biol. Psychiatry 81, 874–885 (2017).
Opris, I. & Casanova, M. F. Prefrontal cortical minicolumn: from executive control to disrupted cognitive processing. Brain 137, 1863–1875 (2014).
Li, Q. et al. Multimodal charting of molecular and functional cell states via in situ electro-sequencing. Cell 186, 2002–2017.e21 (2023).
Billeh, Y. N. et al. Systematic integration of structural and functional data into multi-scale models of mouse primary visual cortex. Neuron 106, 388–403.e18 (2020).
Buchin, A. et al. Multi-modal characterization and simulation of human epileptic circuitry. Cell Rep. 41, 111873 (2022).
Winkler, E. A. et al. A single-cell atlas of the normal and malformed human brain vasculature. Science 375, eabi7377 (2022). This study describes an example of how an ex vivo platform can be utilized to study non-neuronal cell types in human brain and disease.
Eugène, E. et al. An organotypic brain slice preparation from adult patients with temporal lobe epilepsy. J. Neurosci. Methods 235, 234–244 (2014).
Schwarz, N. et al. Long-term adult human brain slice cultures as a model system to study human CNS circuitry and disease. eLife 8, e48417 (2019).
Mich, J. K. et al. Functional enhancer elements drive subclass-selective expression from mouse to primate neocortex. Cell Rep. 34, 108754 (2021).
Zhu, D. et al. Optimal trade-off control in machine learning-based library design, with application to adeno-associated virus (AAV) for gene therapy. Sci. Adv. 10, eadj3786 (2024).
Mercuri, E., Pera, M. C., Scoto, M., Finkel, R. & Muntoni, F. Spinal muscular atrophy—insights and challenges in the treatment era. Nat. Rev. Neurol. 16, 706–715 (2020).
Neuner, S. M., Tcw, J. & Goate, A. M. Genetic architecture of Alzheimer’s disease. Neurobiol. Dis. 143, 104976 (2020).
Tabrizi, S. J., Flower, M. D., Ross, C. A. & Wild, E. J. Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat. Rev. Neurol. 16, 529–546 (2020).
Niestroj, L. M. et al. Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects. Brain 143, 2106–2118 (2020).
Epi4K Consortiu. De novo mutations in epileptic encephalopathies. Nature 501, 217–221 (2013).
Wang, T. et al. Integrated gene analyses of de novo variants from 46,612 trios with autism and developmental disorders. Proc. Natl Acad. Sci. USA 119, e2203491119 (2022).
Fu, J. M. et al. Rare coding variation provides insight into the genetic architecture and phenotypic context of autism. Nat. Genet. 54, 1320–1331 (2022).
Singh, T. et al. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature 604, 509–516 (2022).
Liu, D. et al. Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations. Nat. Genet. 55, 369–376 (2023).
Lin, X. et al. Integrating genetic structural variations and whole-genome sequencing into clinical neurology. Neurol. Genet. 8, e200005 (2022).
Neale, B. M. et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242–245 (2012).
Mitra, I. et al. Patterns of de novo tandem repeat mutations and their role in autism. Nature 589, 246–250 (2021).
Nishioka, M., Bundo, M., Iwamoto, K. & Kato, T. Somatic mutations in the human brain: implications for psychiatric research. Mol. Psychiatry 24, 839–856 (2019).
Rehen, S. K. et al. Constitutional aneuploidy in the normal human brain. J. Neurosci. 25, 2176–2180 (2005).
Wang, Y. et al. Comprehensive identification of somatic nucleotide variants in human brain tissue. Genome Biol. 22, 92 (2021).
Luquette, L. J. et al. Single-cell genome sequencing of human neurons identifies somatic point mutation and indel enrichment in regulatory elements. Nat. Genet. 54, 1564–1571 (2022).
Chung, C. et al. Comprehensive multi-omic profiling of somatic mutations in malformations of cortical development. Nat. Genet. 55, 209–220 (2023).
Hua, Y. & Crino, P. B. Single cell lineage analysis in human focal cortical dysplasia. Cereb. Cortex 13, 693–699 (2003).
Rivière, J. B. et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat. Genet. 44, 934–940 (2012).
Poduri, A. et al. Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 74, 41–48 (2012).
Ribierre, T. et al. Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy. J. Clin. Invest. 128, 2452–2458 (2018).
Baldassari, S. et al. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study. Acta Neuropathol. 138, 885–900 (2019).
Wirrell, E. C. et al. Optimizing the diagnosis and management of dravet syndrome: recommendations from a North American consensus panel. Pediatr. Neurol. 68, 18–34.e3 (2017).
Gratuze, M., Leyns, C. E. G. & Holtzman, D. M. New insights into the role of TREM2 in Alzheimer’s disease. Mol. Neurodegener. 13, 66 (2018).
Ulland, T. K. & Colonna, M. TREM2—a key player in microglial biology and Alzheimer disease. Nat. Rev. Neurol. 14, 667–675 (2018).
Braasch, D. A., Liu, Y. & Corey, D. R. Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design. Nucleic Acids Res. 30, 5160–5167 (2002).
Bladen, C. L. et al. The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations. Hum. Mutat. 36, 395–402 (2015).
Finkel, R. S. et al. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet 388, 3017–3026 (2016).
Hampel, H. et al. The foundation and architecture of precision medicine in neurology and psychiatry. Trends Neurosci. 46, 176–198 (2023).
Knowles, J. K. et al. Precision medicine for genetic epilepsy on the horizon: recent advances, present challenges, and suggestions for continued progress. Epilepsia 63, 2461–2475 (2022).
Varma, V. R. et al. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study. PLoS Med. 15, e1002482 (2018).
Noori, A., Mezlini, A. M., Hyman, B. T., Serrano-Pozo, A. & Das, S. Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration. Neurobiol. Dis. 149, 105225 (2021).
Quazi, S. Artificial intelligence and machine learning in precision and genomic medicine. Med. Oncol. 39, 120 (2022).
Ingusci, S., Verlengia, G., Soukupova, M., Zucchini, S. & Simonato, M. Gene therapy tools for brain diseases. Front. Pharmacol. 10, 724 (2019).
Zhu, D., Schieferecke, A. J., Lopez, P. A. & Schaffer, D. V. Adeno-associated virus vector for central nervous system gene therapy. Trends Mol. Med. 27, 524–537 (2021).
Sugarman, E. A. et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur. J. Hum. Genet. 20, 27–32 (2012).
Mendell, J. R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N. Engl. J. Med. 377, 1713–1722 (2017).
Mendell, J. R. et al. Current clinical applications of in vivo gene therapy with AAVs. Mol. Ther. 29, 464–488 (2021).
Chien, Y. H. et al. Efficacy and safety of AAV2 gene therapy in children with aromatic l-amino acid decarboxylase deficiency: an open-label, phase 1/2 trial. Lancet Child Adolesc. Health 1, 265–273 (2017).
Leone, P. et al. Long-term follow-up after gene therapy for canavan disease. Sci. Transl. Med. 4, 165ra163 (2012).
Chan, K. Y. et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci. 20, 1172–1179 (2017).
Challis, R. C. et al. Adeno-associated virus toolkit to target diverse brain cells. Annu. Rev. Neurosci. 45, 447–469 (2022).
Byrne, L. C. et al. In vivo-directed evolution of adeno-associated virus in the primate retina. JCI Insight 5, e135112 (2020).
Hendriks, S. et al. Ethical challenges of risk, informed consent, and posttrial responsibilities in human research with neural devices: a review. JAMA Neurol. 76, 1506–1514 (2019).
Loyola-Gonzalez, O. Black-box vs. white-box: understanding their advantages and weaknesses from a practical point of view. IEEE Access 7, 154096–154113 (2019).
McLean, S. et al. The risks associated with artificial general intelligence: a systematic review. J. Exp. Theor. Artif. Intell. 35, 649–663 (2023).
Feinsinger, A. et al. Ethical commitments, principles, and practices guiding intracranial neuroscientific research in humans. Neuron 110, 188–194 (2022).
Kaiser, J. & Brainard, J. Ready, set, share. Science 379, 322–325 (2023).
von Thenen, N., Ayday, E. & Cicek, A. E. Re-identification of individuals in genomic data-sharing beacons via allele inference. Bioinformatics 35, 365–371 (2019).
Jansen, P. R. et al. Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways. Nat. Genet. 51, 394–403 (2019).
Choudhury, S., Fishman, J. R., McGowan, M. L. & Juengst, E. T. Big data, open science and the brain: lessons learned from genomics. Front. Hum. Neurosci. 8, 239 (2014).
Van Horn, J. D. & Ball, C. A. Domain-specific data sharing in neuroscience: what do we have to learn from each other. Neuroinformatics 6, 117–121 (2008).
Ford, D. et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet. 62, 676–689 (1998).
Maury, E. A. et al. Schizophrenia-associated somatic copy-number variants from 12,834 cases reveal recurrent NRXN1 and ABCB11 disruptions. Cell Genomics 3, 100356 (2023).
Paré, G. et al. Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. N. Engl. J. Med. 363, 1704–1714 (2010).
Mellinghoff, I. K. et al. Vorasidenib in IDH1– or IDH2-mutant low-grade glioma. N. Engl. J. Med. 389, 589–601 (2023).
Wong, C. UK first to approve CRISPR treatment for diseases: what you need to know. Nature 623, 676–677 (2023).
Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer’s disease. Nature 570, 332–337 (2019).
Yang, A. C. et al. A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk. Nature 603, 885–892 (2022).
Cain, A. et al. Multicellular communities are perturbed in the aging human brain and Alzheimer’s disease. Nat. Neurosci. 26, 1267–1280 (2023).
Yuste, R. et al. A community-based transcriptomics classification and nomenclature of neocortical cell types. Nat. Neurosci. 23, 1456–1468 (2020).
Speir, M. L. et al. UCSC Cell Browser: visualize your single-cell data. Bioinformatics 37, 4578–4580 (2021).
Wan, Z. et al. Sociotechnical safeguards for genomic data privacy. Nat. Rev. Genet. 23, 429–445 (2022).
Ngai, J. BRAIN 2.0: transforming neuroscience. Cell 185, 4–8 (2022).
Reardon, J. et al. Trustworthiness matters: building equitable and ethical science. Cell 186, 894–898 (2023).
Kowal, E. et al. Community partnerships are fundamental to ethical ancient DNA research. HGG Adv. 4, 100161 (2023).
Shim, J. K. et al. Community engagement in precision medicine research: organizational practices and their impacts for equity. AJOB Empir. Bioeth. 14, 185–196 (2023).
Han, H. R. et al. Exploring community engaged research experiences and preferences: a multi-level qualitative investigation. Res. Involv. Engagem. 7, 19 (2021).
Vollger, M. R. et al. Segmental duplications and their variation in a complete human genome. Science 376, eabj6965 (2022).
Wang, T. et al. The Human Pangenome Project: a global resource to map genomic diversity. Nature 604, 437–446 (2022).
Hodge, R. D. et al. Conserved cell types with divergent features in human versus mouse cortex. Nature 573, 61–68 (2019).
Berg, J. et al. Human neocortical expansion involves glutamatergic neuron diversification. Nature 598, 151–158 (2021).
Jorstad, N. L. et al. Transcriptomic cytoarchitecture reveals principles of human neocortex organization. Science 382, eadf6812 (2023).
Elston, G. N. Cortex, cognition and the cell: new insights into the pyramidal neuron and prefrontal function. Cereb. Cortex 13, 1124–1138 (2003).
Hill, R. S. & Walsh, C. A. Molecular insights into human brain evolution. Nature 437, 64–67 (2005).
Markov, N. T. et al. Cortical high-density counterstream architectures. Science 342, 1238406 (2013).
Nowakowski, T. J., Pollen, A. A., Sandoval-Espinosa, C. & Kriegstein, A. R. Transformation of the radial glia scaffold demarcates two stages of human cerebral cortex development. Neuron 91, 1219–1227 (2016).
Huttenlocher, P. R. & Dabholkar, A. S. Regional differences in synaptogenesis in human cerebral cortex. J. Comp. Neurol. 387, 167–178 (1997).
Vanderhaeghen, P. & Polleux, F. Developmental mechanisms underlying the evolution of human cortical circuits. Nat. Rev. Neurosci. 24, 213–232 (2023).
Roberts, R. J. V., Pop, S. & Prieto-Godino, L. L. Evolution of central neural circuits: state of the art and perspectives. Nat. Rev. Neurosci. 23, 725–743 (2022).
Kebschull, J. M. et al. Cerebellar nuclei evolved by repeatedly duplicating a conserved cell-type set. Science 370, eabd5059 (2020).
Defelipe, J. The evolution of the brain, the human nature of cortical circuits, and intellectual creativity. Front. Neuroanat. 5, 29 (2011).
